Information Journal Paper
APA:
Copy. (2017). Safety and efficacy of erenumab for preventive treatment of chronic migraine: a randomised, double-blind, placebo-controlled phase 2 trial. LANCET NEUROLOGY, 16(-), 425-434. SID. https://sid.ir/paper/774806/en
Vancouver:
Copy. Safety and efficacy of erenumab for preventive treatment of chronic migraine: a randomised, double-blind, placebo-controlled phase 2 trial. LANCET NEUROLOGY[Internet]. 2017;16(-):425-434. Available from: https://sid.ir/paper/774806/en
IEEE:
Copy, “Safety and efficacy of erenumab for preventive treatment of chronic migraine: a randomised, double-blind, placebo-controlled phase 2 trial,” LANCET NEUROLOGY, vol. 16, no. -, pp. 425–434, 2017, [Online]. Available: https://sid.ir/paper/774806/en